$PGNX PROGENICS PHARMACEUTICALS INC Insider Trading Week 25/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PROGENICS PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in PROGENICS PHARMACEUTICALS INC in week 25/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Das Asha | Chief Medical Offic ... | Option Exercise | D | 4.77 | 82,214 | 392,161 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Das Asha | Chief Medical Offic ... | Option Exercise | D | 4.56 | 125,000 | 570,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Das Asha | Chief Medical Offic ... | Option Exercise | D | 4.77 | 82,214 | 392,161 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Das Asha | Chief Medical Offic ... | Option Exercise | D | 4.56 | 125,000 | 570,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Osorio Benedict | COO | Option Exercise | D | 4.77 | 82,214 | 392,161 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Osorio Benedict | COO | Option Exercise | D | 4.52 | 90,750 | 410,190 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Osorio Benedict | COO | Option Exercise | D | 4.77 | 82,214 | 392,161 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Osorio Benedict | COO | Option Exercise | D | 6.62 | 100,000 | 662,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Osorio Benedict | COO | Option Exercise | D | 4.52 | 90,750 | 410,190 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Osorio Benedict | COO | Sell | D | 0.00 | 21,202 | 0 | 0 | 21.2 K to 0 (-100.00 %) |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Osorio Benedict | COO | Option Exercise | D | 6.62 | 100,000 | 662,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Osorio Benedict | COO | Sell | D | 0.00 | 21,202 | 0 | 0 | 21.2 K to 0 (-100.00 %) |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Tenbarge Bryce | SVP, Commercial | Option Exercise | D | 4.77 | 82,214 | 392,161 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Tenbarge Bryce | SVP, Commercial | Option Exercise | D | 4.52 | 90,750 | 410,190 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Tenbarge Bryce | SVP, Commercial | Option Exercise | D | 4.77 | 82,214 | 392,161 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Tenbarge Bryce | SVP, Commercial | Option Exercise | D | 6.62 | 75,900 | 502,458 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Tenbarge Bryce | SVP, Commercial | Option Exercise | D | 4.52 | 90,750 | 410,190 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Tenbarge Bryce | SVP, Commercial | Option Exercise | D | 11.32 | 66,000 | 747,120 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Tenbarge Bryce | SVP, Commercial | Option Exercise | D | 6.62 | 75,900 | 502,458 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Tenbarge Bryce | SVP, Commercial | Option Exercise | D | 6.77 | 75,000 | 507,750 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Tenbarge Bryce | SVP, Commercial | Option Exercise | D | 11.32 | 66,000 | 747,120 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 4.77 | 82,214 | 392,161 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Tenbarge Bryce | SVP, Commercial | Option Exercise | D | 6.77 | 75,000 | 507,750 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 4.52 | 90,750 | 410,190 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 4.77 | 82,214 | 392,161 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 6.62 | 94,875 | 628,073 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 4.52 | 90,750 | 410,190 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 11.32 | 82,500 | 933,900 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 6.62 | 94,875 | 628,073 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 4.52 | 82,500 | 372,900 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 11.32 | 82,500 | 933,900 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 6.65 | 66,000 | 438,900 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 4.52 | 82,500 | 372,900 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 4.70 | 75,000 | 352,500 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 6.65 | 66,000 | 438,900 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 4.70 | 52,800 | 248,160 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 4.70 | 75,000 | 352,500 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 5.03 | 48,000 | 241,440 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 4.70 | 52,800 | 248,160 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 9.81 | 40,000 | 392,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 5.03 | 48,000 | 241,440 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 7.40 | 60,000 | 444,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 9.81 | 40,000 | 392,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 4.83 | 25,000 | 120,750 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 7.40 | 60,000 | 444,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 5.35 | 6,000 | 32,100 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 4.83 | 25,000 | 120,750 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Sell | D | 0.00 | 4,121 | 0 | 0 | 4.1 K to 0 (-100.00 %) |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 5.35 | 6,000 | 32,100 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Mims David W. | Interim CEO and Int ... | Option Exercise | D | 5.01 | 16,393 | 82,129 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Sell | D | 0.00 | 4,121 | 0 | 0 | 4.1 K to 0 (-100.00 %) |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Mims David W. | Interim CEO and Int ... | Option Exercise | D | 5.01 | 40,000 | 200,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Mims David W. | Interim CEO and Int ... | Option Exercise | D | 5.01 | 16,393 | 82,129 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Mims David W. | Interim CEO and Int ... | Option Exercise | D | 5.01 | 40,000 | 200,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ber Gerard | Director | Option Exercise | D | 5.01 | 16,393 | 82,129 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ber Gerard | Director | Option Exercise | D | 5.01 | 40,000 | 200,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ber Gerard | Director | Option Exercise | D | 5.01 | 16,393 | 82,129 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ber Gerard | Director | Sell | D | 0.00 | 50,000 | 0 | 0 | 50 K to 0 (-100.00 %) |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ber Gerard | Director | Option Exercise | D | 5.01 | 40,000 | 200,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ber Gerard | Director | Sell | D | 0.00 | 50,000 | 0 | 0 | 50 K to 0 (-100.00 %) |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Director | Option Exercise | D | 5.74 | 25,000 | 143,500 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Director | Option Exercise | D | 8.99 | 25,000 | 224,750 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Director | Option Exercise | D | 5.74 | 25,000 | 143,500 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Director | Option Exercise | D | 6.95 | 20,000 | 139,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Director | Option Exercise | D | 8.99 | 25,000 | 224,750 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Director | Option Exercise | D | 4.89 | 28,000 | 136,920 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Director | Option Exercise | D | 6.95 | 20,000 | 139,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Director | Sell | D | 0.00 | 12,000 | 0 | 0 | 12 K to 0 (-100.00 %) |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Director | Option Exercise | D | 4.89 | 28,000 | 136,920 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Director | Sell | D | 0.00 | 12,000 | 0 | 0 | 12 K to 0 (-100.00 %) |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ende Eric J | Director | Option Exercise | D | 5.01 | 16,393 | 82,129 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ende Eric J | Director | Option Exercise | D | 5.01 | 40,000 | 200,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ende Eric J | Director | Option Exercise | D | 5.01 | 16,393 | 82,129 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ende Eric J | Director | Option Exercise | D | 5.01 | 40,000 | 200,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 5.74 | 25,000 | 143,500 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 8.99 | 25,000 | 224,750 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 5.74 | 25,000 | 143,500 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 6.95 | 20,000 | 139,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 8.99 | 25,000 | 224,750 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 4.89 | 20,000 | 97,800 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 6.95 | 20,000 | 139,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 6.72 | 20,000 | 134,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 4.89 | 20,000 | 97,800 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 4.47 | 20,000 | 89,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 6.72 | 20,000 | 134,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 4.50 | 40,000 | 180,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 4.47 | 20,000 | 89,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 4.50 | 40,000 | 180,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | MacDougall Ann L. | Director | Option Exercise | D | 5.01 | 36,065 | 180,686 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | MacDougall Ann L. | Director | Option Exercise | D | 5.01 | 40,000 | 200,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | MacDougall Ann L. | Director | Option Exercise | D | 5.01 | 36,065 | 180,686 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | MacDougall Ann L. | Director | Option Exercise | D | 5.01 | 40,000 | 200,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Maeusli Heinz Christoph | Director | Option Exercise | D | 5.01 | 16,393 | 82,129 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Maeusli Heinz Christoph | Director | Option Exercise | D | 5.01 | 40,000 | 200,400 | 0 |